Publications by authors named "I Dedov"

Bariatric surgery is known to induce weight loss and diabetes remission in patients with type 2 diabetes (T2D), but the exact mechanism of glycemic normalization needs to be defined. The study included patients with BMI ≥ 35 kg/m, obesity history ≥ 10 years, and planned bariatric surgery. At baseline and 3 and 6 months after surgery, all patients underwent anthropometric measurements, body composition and blood tests (including insulin, glucagon, and incretins during oral glucose tolerance test (OGTT)), and hyperinsulinemic euglycemic clamp tests.

View Article and Find Full Text PDF

Using analytical technologies it is possible now to measure the entire diversity of molecules even in a small amount of biological samples. Metabolomic technologies simultaneously analyze thousands of low-molecular substances in a single drop of blood. Such analytical performance opens new possibilities for clinical laboratory diagnostics, still relying on the measurement of only a limited number of clinically significant substances.

View Article and Find Full Text PDF

Background: Patients with diabetes mellitus (DM) are at risk for a higher incidence and severity of COVID-19, as well as its adverse outcomes, including post-Covid syndrome.

Aim: to assess the incidence of cardiorenal complications in patients with type 1 and type 2 diabetes (T1DM/T2DM) who have had COVID-19, and to analyze the structure and severity of disorders according to examination data at the Diamobil mobile medical diagnostic and treatment center.

Materials And Methods: a cohort of T1DM and T2DM patients examined in Diamobil (n=318), with a confirmed anamnesis of COVID-19 (n=236).

View Article and Find Full Text PDF

In this paper, the genus Fitzinger, 1833 in Serbia is reviewed. All previous literature data on this genus from Serbia are summarised and used to discuss its distribution in the country and create distribution maps, supplemented by new material collected by the authors. All Serbian species are figured.

View Article and Find Full Text PDF
Article Synopsis
  • The clinical blood metabogram (CBM) is a tailored blood test designed to analyze metabolite groups while being efficient in time, cost, and reproducibility for clinical settings.
  • The study evaluated the CBM in 18 healthy individuals, 12 prediabetics, and 64 type 2 diabetes patients, identifying significant metabolic changes related to diabetes, such as alterations in carbohydrates, ketone bodies, and amino acids.
  • The CBM proved effective in distinguishing metabolic differences among diabetic patients, offering valuable insights for diagnosing and managing diabetes.
View Article and Find Full Text PDF